packaging프리미엄

Pharmaceutical Packaging: Where Serialization Meets Sustainability

February 12, 20269 분 소요
pharmaceuticalserializationsustainabilityblister packs

핵심 요약

Pharma packaging faces unique dual-regulation pressure. Serialization + sustainability requires innovative solutions that don't compromise patient safety.

Pharmaceutical packaging sits at the intersection of two regulatory forces.

Serialization Requirements

  • EU FMD (Falsified Medicines Directive) requires tamper-evident features
  • US DSCSA requires full product tracing by November 2026
  • These mandates often require additional packaging layers and materials

    • Sustainability Pressure

  • PPWR applies to pharmaceutical packaging (limited exemptions)
  • Healthcare plastic waste estimated at 5.9 million tonnes annually in EU
  • Patient safety vs recyclability creates genuine design conflicts

    • Solutions Emerging

  • Digital watermarks replacing physical tamper-evidence
  • Mono-material blister packs (all-PP replacing PVC/Alu)
  • Refillable/reusable systems for chronic medication

    • 데이터 출처

    EMA, FDA, Healthcare Plastics Recycling Council, PDA

    영향

    Pharma packaging teams should engage PPWR compliance AND serialization requirements simultaneously. Siloed approaches will create costly redesigns.

    전체 분석을 읽으려면 구독하세요

    Get unlimited access to premium analysis, daily briefings, and compliance tools.